Top 15 Companies in Global Artificial Heart 2025: Market Intelligence And Investment Trends (2024–2035)

Description

According to a research report published by Spherical Insights & Consulting, the Global Artificial Heart Market Size is projected to grow from USD 2.73 Billion in 2024 to USD 7.15 Billion by 2035, at a CAGR of 9.15% during the forecast period 2024–2035. The global artificial heart market is growing due to rising prevalence of cardiovascular diseases, increasing demand for advanced cardiac support devices, limited donor organ availability, and continuous technological advancements, which are increasing adoption across multiple industries and supporting overall market expansion.

 

Introduction

The artificial heart market encompasses mechanical devices designed to replace or support the function of a failing human heart. The system operates through total artificial hearts and ventricular assist devices (VADs) and implantable pumps, which create continuous blood flow and heart support. Artificial hearts serve their primary function as medical devices that assist patients undergoing end-stage heart failure until they receive heart transplants or when transplants become medically impossible. The market expands because more people develop cardiovascular diseases while donor organs remain scarce, and hospitals adopt new cardiac support technologies. The latest innovations feature small, complete implantable systems that demonstrate better compatibility with biological systems and have power-efficient blood circulation systems. The worldwide product development process depends on regulatory standards, which establish device safety requirements and clinical trial protocols. Miniaturized devices that maintain durability will create new business opportunities when combined with remote monitoring systems and implementation in developing healthcare markets.

 

Navigate Future Markets with Confidence: Insights from Spherical Insights LLP

The insights presented in this blog are derived from comprehensive market research conducted by Spherical Insights LLP, a trusted advisory partner to leading global enterprises. Backed by in-depth data analysis, expert forecasting, and industry-specific intelligence, our reports empower decision-makers to identify strategic growth opportunities in fast-evolving sectors. Clients seeking detailed market segmentation, competitive landscapes, regional outlooks, and future investment trends will find immense value in the full report. By leveraging our research, businesses can make informed decisions, gain a competitive edge, and stay ahead in the transition toward sustainable and profitable solutions.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global artificial heart market.

 

Segment Insights: Key Segments Shaping Market Growth

 

Global Artificial Heart Market Size, Share, By Type (Total Artificial Heart, Partial Artificial Heart, Ventricular Assist Device, Biventricular Assist Device), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Home Care Settings), By Application (Cardiac Replacement, Cardiac Support, Heart Valve Replacement, Heart Failure Management), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2024 – 2035

 

Global Artificial Heart Market Size & Statistics

• The Market Size for Global Artificial Heart Was Estimated to be worth USD 2.73 Billion in 2024.
• The Market is Going to Expand at a CAGR of 9.15% between 2024 and 2035.
• The Global Artificial Heart Market Size is anticipated to reach USD 7.15 Billion by 2035.
• North America is expected to generate the largest demand during the forecast period in the Global Artificial Heart Market
• Asia Pacific is expected to grow the fastest during the forecast period in the Global Artificial Heart Market.

 

Regional growth and demand

                                    

Asia Pacific is expected to grow the fastest during the forecast period in the global artificial heart market. Asia Pacific is the most rapidly expanding region, driven by the rising prevalence of cardiovascular diseases, expanding healthcare infrastructure, and increasing adoption of advanced cardiac support devices. Investments in cutting-edge artificial heart technologies and supportive hospital systems are accelerating. Government healthcare initiatives, rising patient awareness, and growing local competition are driving innovation, creating highly profitable opportunities for regional and international providers.

 

North America is expected to generate the largest demand during the forecast period in the global artificial heart market. The global artificial heart market is dominated by North America due to advanced healthcare facilities, strong hospital networks, high cardiac disease prevalence, and widespread adoption of technologically advanced artificial heart systems. Leading players such as Abiomed and SynCardia drive continuous innovation. Government-backed reimbursement policies, research funding, and established cardiac care programs maintain stable growth, positioning the region as a global hub for artificial heart adoption.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global artificial heart market.

 

Top 10 Trends in the Global Artificial Heart Market

• Increasing adoption of ventricular assist devices (VADs) and total artificial hearts
• Miniaturization and fully implantable designs
• Integration with remote monitoring and telemetry systems
• Use of advanced biocompatible and hemocompatible materials
• Energy-efficient and durable pumping mechanisms
• Personalized and patient-specific device designs
• Hybrid cardiac support systems
• Enhanced surgical planning and 3D simulation tools
• Integration with regenerative medicine research
• Regulatory and clinical trial process innovations

 

1. Increasing adoption of ventricular assist devices (VADs) and total artificial hearts

The growing demand for ventricular assist devices and total artificial hearts drives the global artificial heart market by providing life-saving cardiac support for patients with end-stage heart failure. This trend improves patient survival, mobility, and quality of care, accelerating adoption across hospitals and speciality clinics.

 

2. Miniaturization and fully implantable designs

The development of miniaturized and fully implantable artificial hearts leads the market by enabling smaller, more comfortable, and infection-resistant devices. This trend enhances surgical feasibility, patient compliance, and long-term implantation success, fostering innovation in device engineering and patient-specific solutions.

 

3. Integration with remote monitoring and telemetry systems

The integration of remote monitoring and telemetry in artificial hearts enhances real-time tracking of device performance and patient cardiac health. This trend improves clinical decision-making, early detection of complications, and overall operational efficiency in cardiac care settings worldwide.

 

4. Use of advanced biocompatible and hemocompatible materials

The adoption of advanced biocompatible and hemocompatible materials improves device safety and reduces clotting, inflammation, and other complications. This trend drives market growth by enhancing patient outcomes, supporting regulatory compliance, and enabling wider acceptance of mechanical heart support devices.

 

5. Energy-efficient and durable pumping mechanisms

The development of energy-efficient and durable pumping mechanisms strengthens the market by increasing device reliability, longevity, and performance. This trend enhances clinical outcomes, reduces maintenance needs, and supports broader adoption of artificial heart systems across hospitals and home care settings.

 

Empower your strategic planning:

Stay informed with the latest industry insights and market trends to identify new opportunities and drive growth in the global artificial heart market. To explore more in-depth trends, insights, and forecasts, please refer to our detailed report.

 

 

Top 15 Companies Leading the Global Artificial Heart Market

1. Abbott Laboratories
2. Medtronic
3. Abiomed
4. Boston Scientific Corporation
5. SynCardia Systems, LLC
6. CARMAT SA
7. BiVACOR Inc.
8. Berlin Heart GmbH
9. Jarvik Heart, Inc.
10. Terumo Corporation
11. LivaNova PLC
12. Getinge AB
13. ReliantHeart, Inc.
14. CryoLife, Inc.
15. RealHeart

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global artificial heart market.

 

1. Abbott Laboratories

Headquarters: Abbott Park, Illinois, USA

Abbott Laboratories is a global healthcare company specializing in medical devices and therapies. In the artificial heart market, it is a leading provider of the HeartMate 3 left ventricular assist device (LVAD), which supports patients with advanced heart failure. Abbott’s LVAD technology uses fully magnetically levitated flow to improve durability and reduce complications. The company drives innovation in mechanical circulatory support by enhancing device efficiency, safety, and long-term patient outcomes, reinforcing its leadership position globally.

 

2. Medtronic plc

Headquarters: Dublin, Ireland

Medtronic plc is a medical technology leader with a focus on cardiovascular therapies. In the artificial heart market, the company offers ventricular assist devices and related cardiac support solutions for advanced heart failure. Medtronic’s products contribute to procedural efficiency, patient safety, and improved hemodynamic support. By continuously advancing device technology and operational support systems, the company strengthens innovation, promotes treatment accessibility, and supports sustainable growth in the mechanical circulatory support segment worldwide.

 

3. Abiomed

Headquarters: Danvers, Massachusetts, USA

Abiomed develops percutaneous mechanical circulatory support devices, primarily the Impella heart pump systems. These devices provide temporary ventricular support during high-risk cardiac interventions and acute heart failure. In the artificial heart market, Abiomed’s solutions enable rapid hemodynamic stabilization and improved procedural outcomes. The company advances innovation through minimally invasive technologies, enhances patient safety, and contributes to market growth by expanding the use of efficient, temporary circulatory support solutions in critical cardiac care.

 

4. Boston Scientific Corporation

Headquarters: Marlborough, Massachusetts, USA

Boston Scientific Corporation is a global medical device company providing cardiovascular and interventional technologies. In the artificial heart market, the company supports mechanical circulatory systems by offering complementary tools and devices that facilitate heart failure interventions. Boston Scientific contributes to market innovation by improving procedural efficiency and patient management. Its technologies support broader adoption of circulatory support therapies, enhance treatment safety, and help drive the growth of advanced cardiac care solutions worldwide.

 

5. SynCardia Systems, LLC

Headquarters: Tucson, Arizona, USA

SynCardia Systems, LLC specializes in total artificial heart solutions and is the only provider of a clinically proven, commercially approved total artificial heart. Its devices provide bridge-to-transplant support for patients with end-stage biventricular heart failure. SynCardia’s technologies include portable and hospital driver systems, enabling continuous circulatory support. The company contributes to market growth by advancing full heart replacement options, improving patient survival, operational efficiency, and accessibility of mechanical circulatory support for critical heart failure cases.

 

Are you ready to discover more about the global artificial heart market?

The report provides an in-depth analysis of the leading companies operating in the global artificial heart market. It includes a comparative assessment based on their product portfolios, business overviews, geographical footprint, strategic initiatives, market segment share, and SWOT analysis. Each company is profiled using a standardized format that includes:

 

Company Profiles

1. Abbott Laboratories

• Business Overview
• Company Snapshot
• Products Overview
• Company Market Share Analysis
• Company Coverage Portfolio
• Financial Analysis
• Recent Developments
• Merger and Acquisitions
• SWOT Analysis

 

2. Medtronic
3. Abiomed
4. Boston Scientific Corporation
5. SynCardia Systems, LLC
6. CARMAT SA
7. BiVACOR Inc.
8. Berlin Heart GmbH
9. Jarvik Heart, Inc.
10. Others

 

Our Reports

https://www.sphericalinsights.com/reports/japan-sports-tourism-market

https://www.sphericalinsights.com/reports/butyl-methacrylate-market

 

Conclusion

The global artificial heart market is expanding rapidly, driven by rising cardiovascular disease prevalence, limited donor organ availability, and continuous technological advancements. Key trends include miniaturization, fully implantable designs, integration with remote monitoring systems, and the use of biocompatible materials, which enhance patient outcomes and operational efficiency. North America leads the market with high adoption of advanced devices, while Asia-Pacific shows the fastest growth due to improving healthcare infrastructure. Leading companies such as Abbott, Medtronic, Abiomed, and SynCardia are driving innovation, improving accessibility, and shaping the future of mechanical circulatory support worldwide.

 

Unlock exclusive market insights—Download the Brochure now and dive deeper into the future of the global artificial heart market.

 

About the Spherical Insights & Consulting

Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI. Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements. 

 

CONTACT US:

For More Information on Your Target Market, Please Contact Us Below:    

Phone: +1 303 800 4326 (the U.S.)

Phone: +91 90289 24100 (APAC)

Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com

Contact Us: https://www.sphericalinsights.com/contact-us

Follow Us: LinkedIn | Facebook | Twitter